DRX DLY S&P Biotech Bull 3XETF
13F holders, Q4 2024 (December 31)6holders +2
2new positions
0sold out
$90.12avg. 13F price*
At the end of Q4 2024, 6 institutions reported holding DRX DLY S&P Biotech Bull 3X in their 13F filings, up 2 from Q3 2024. 2 opened new positions and 0 sold out. The largest holders were Parallel Advisors, LLC ($70K), Lindbrook Capital, LLC ($67K) and EverSource Wealth Advisors, LLC ($9K).
- Company
- DRX DLY S&P Biotech Bull 3X
- Filed as
- DIREXION DAILY S&P BIOTECH BULL 3X SHARES (Q4 2024)
- CUSIP
- 25490K323
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $11K |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 611 shares bought, net +611 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Parallel Advisors, LLC | 0.00% | Add +19.1% | 780 | $70K |
| Lindbrook Capital, LLC | 0.01% | Add +84.0% | 745 | $67K |
| EverSource Wealth Advisors, LLC | 0.00% | New | 98 | $9K |
| Hollencrest Capital Management | 0.00% | Add +175.0% | 44 | $4K |
| Cornerstone Planning Group LLC | 0.00% | No change | 35 | $3K |
| Pension & Wealth Management Advisors, Inc. | 0.00% | New | 20 | $2K |
"% of holder's portfolio" is DRX DLY S&P BIOTECH BULL 3X's weight in each manager's 13F, not the share of DRX DLY S&P Biotech Bull 3X the manager owns.